Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CureVac N.V. stock logo
CVAC
CureVac
$4.66
$4.66
$3.13
$5.72
$960.17M1.77992,546 shsN/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$3.62
+6.8%
$3.44
$2.50
$33.40
$5.22M1.56140,108 shs92,538 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CureVac N.V. stock logo
CVAC
CureVac
0.00%0.00%0.00%0.00%+4.95%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
0.00%+14.20%+17.15%-32.61%-68.89%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CureVac N.V. stock logo
CVAC
CureVac
$4.66
$4.66
$3.13
$5.72
$960.17M1.77992,546 shsN/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$3.62
+6.8%
$3.44
$2.50
$33.40
$5.22M1.56140,108 shs92,538 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CureVac N.V. stock logo
CVAC
CureVac
0.00%0.00%0.00%0.00%+4.95%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
0.00%+14.20%+17.15%-32.61%-68.89%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CureVac N.V. stock logo
CVAC
CureVac
1.80
Reduce$5.2512.66% Upside
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
1.50
ReduceN/AN/A

Current Analyst Ratings Breakdown

Latest HTCR and CVAC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2026
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
DowngradeSell (D+)Sell (D)
3/27/2026
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
Reiterated RatingSell (D-)
(Data available from 5/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CureVac N.V. stock logo
CVAC
CureVac
$70.74M14.78$0.99 per share4.73$3.36 per share1.39
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$8.97M0.58N/AN/A$3.17 per share1.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CureVac N.V. stock logo
CVAC
CureVac
$175.50M$0.726.47N/AN/A199.92%-23.03%-19.09%N/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$5.79M-$2.29N/AN/AN/A-67.96%-115.26%-35.28%8/17/2026 (Estimated)

Latest HTCR and CVAC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
-$0.03-$1.49-$1.46-$1.49$5.50 million$1.25 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CureVac N.V. stock logo
CVAC
CureVac
N/AN/AN/AN/AN/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CureVac N.V. stock logo
CVAC
CureVac
0.03
3.70
3.69
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
0.10
1.17
1.17

Institutional Ownership

CompanyInstitutional Ownership
CureVac N.V. stock logo
CVAC
CureVac
17.26%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
1.71%

Insider Ownership

CompanyInsider Ownership
CureVac N.V. stock logo
CVAC
CureVac
2.15%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
57.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
CureVac N.V. stock logo
CVAC
CureVac
880224.34 million219.52 millionOptionable
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
401.44 million614,000Not Optionable

Recent News About These Companies

HeartCore Reports First Quarter 2026 Financial Results
HeartCore Executes 1-for-20 Reverse Stock Split
HeartCore Announces 1-for-20 Reverse Stock Split
HeartCore Reports Full Year 2025 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

CureVac stock logo

CureVac NASDAQ:CVAC

$4.66 0.00 (0.00%)
As of 05/29/2026

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

HeartCore Enterprises stock logo

HeartCore Enterprises NASDAQ:HTCR

$3.62 +0.23 (+6.78%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$3.44 -0.18 (-4.97%)
As of 05/29/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HeartCore Enterprises, Inc., a software development company, provides Software as a Service solutions to enterprise customers in Japan and internationally. Its customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. The company also operates a digital transformation business that offers customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises. In addition, it provides consulting services; and education, services, and support solutions. The company was founded in 2009 and is headquartered in Tokyo, Japan.